U.S. flag

An official website of the United States government

NM_002834.5(PTPN11):c.226G>A (p.Glu76Lys) AND Malignant neoplastic disease

Germline classification:
Uncertain significance (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001254876.2

Allele description [Variation Report for NM_002834.5(PTPN11):c.226G>A (p.Glu76Lys)]

NM_002834.5(PTPN11):c.226G>A (p.Glu76Lys)

Gene:
PTPN11:protein tyrosine phosphatase non-receptor type 11 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q24.13
Genomic location:
Preferred name:
NM_002834.5(PTPN11):c.226G>A (p.Glu76Lys)
Other names:
p.E76K:GAG>AAG
HGVS:
  • NC_000012.12:g.112450406G>A
  • NG_007459.1:g.36675G>A
  • NM_001330437.2:c.226G>A
  • NM_001374625.1:c.223G>A
  • NM_002834.4:c.226G>A
  • NM_002834.5:c.226G>AMANE SELECT
  • NM_080601.3:c.226G>A
  • NP_001317366.1:p.Glu76Lys
  • NP_001317366.1:p.Glu76Lys
  • NP_001361554.1:p.Glu75Lys
  • NP_002825.3:p.Glu76Lys
  • NP_542168.1:p.Glu76Lys
  • LRG_614t1:c.226G>A
  • LRG_614:g.36675G>A
  • NC_000012.11:g.112888210G>A
  • NM_001330437.1:c.226G>A
  • NM_002834.3:c.226G>A
  • Q06124:p.Glu76Lys
Protein change:
E75K; GLU76LYS
Links:
UniProtKB: Q06124#VAR_016000; OMIM: 176876.0014; dbSNP: rs121918464
NCBI 1000 Genomes Browser:
rs121918464
Molecular consequence:
  • NM_001330437.2:c.226G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374625.1:c.223G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002834.5:c.226G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_080601.3:c.226G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Malignant neoplastic disease
Synonyms:
Cancer
Identifiers:
MONDO: MONDO:0004992; MedGen: C0006826

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001424769Investigational Cancer Therapeutics, MD Anderson Cancer Center
no assertion criteria provided
Uncertain significanceunknownresearch

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedresearch

Details of each submission

From Investigational Cancer Therapeutics, MD Anderson Cancer Center, SCV001424769.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providedresearchnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024